Fortune Magazine announced this week that Medtronic has once again been named one of the World’s Most Admired Companies. Medtronic has regularly appeared on the list which dates back to 1997. This is the sixth consecutive year the company has received the honor.

The World’s Most Admired Companies list is considered one of the leading measures of corporate reputation. Along with the Fortune 1,000 list, Global 500 companies and other major non-U.S. companies are considered across more than 50 industry groupings. Organizations are evaluated on nine attributes including innovation, product quality, and long-term investment value.

“We're honored to once again be ranked among Fortune’s Most Admired Companies,” said Medtronic chairman and CEO Geoff Martha. “This recognition is a testament to the dedication of our more than 95,000 employees worldwide, all united by our Mission to alleviate pain, restore health, and extend life. Being named to this prestigious list energizes us to keep pushing forward, driving innovation, and making a positive impact in the world.”

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.medtronic.com and follow Medtronic on LinkedIn. 

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the U.S. Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:

Erika Winkels
Public Relations
+1-763-526-8478

Ryan Weispfenning
Investor Relations
+1-763-505-4626